Nobiletin ameliorates the deficits in hippocampal BDNF, TrkB, and synapsin i induced by chronic unpredictable mild stress

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Li, Jing ^a   Zhou, Ying ^a   Liu, Bin Bin ^a   Liu, Qing ^a   Geng, Di ^a   Weng, Lian Jin ^a   Yi, Li Tao ^a  

^a HUAQIAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; FLUOXETINE; MESSENGER RNA; NEUROTROPHIC FACTOR; NOBILETIN; PROTEIN; SUCROSE; SYNAPSIN I; TFKB PROTEIN; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC STRESS; CHRONIC UNPREDICTABLE MILD STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DEPRESSION; FOOD DEPRIVATION; FOOD PREFERENCE; GENE EXPRESSION; HIPPOCAMPUS; ILLUMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WATER DEPRIVATION; WEIGHT GAIN; WHITE NOISE;

EID: 84876580792     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/359682     Document Type: Article

References (74)

1. World Health Organisation,. Depression, 2007, http://www.who.int/mental- health/management/depression/definition/en/
2. Liu Y., Yang N., Hao W., Zhao Q., Ying T., Liu S., Li Q., Liang Y., Wang T., Dong Y., Ji C., Zuo P., Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/c mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies. Neurochemistry International 2011 58 8 904 913 2-s2.0-79956223925 10.1016/j.neuint.2011.02.019
3. Huang E. J., Reichardt L. F., Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience 2001 24 677 736 2-s2.0-0034927081 10.1146/annurev.neuro.24.1.677 (Pubitemid 32695243)
4. Skaper S. D., The neurotrophin family of neurotrophic factors: an overview. Neurotrophic Factors 2012 846 1 12 Methods in Molecular Biology 10.1007/978-1-61779-536-7-1
5. Heldt S. A., Stanek L., Chhatwal J. P., Ressler K. J., Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Molecular Psychiatry 2007 12 7 656 670 2-s2.0-34247856252 10.1038/sj.mp.4001957 (Pubitemid 46998249)
6. Angelucci F., Brenè S., Mathé A. A., BDNF in schizophrenia, depression and corresponding animal models. Molecular Psychiatry 2005 10 4 345 352 2-s2.0-16844382943 10.1038/sj.mp.4001637
7. Castrén E., Rantamäki T., The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010 70 5 289 297 10.1002/dneu.20758
8. Li W., Keifer J., Rapid enrichment of presynaptic protein in boutons undergoing classical conditioning is mediated by brain-derived neurotrophic factor. Neuroscience 2012 203 50 58 10.1016/j.neuroscience.2011.12.015
9. Fahnestock M., Marchese M., Head E., Pop V., Michalski B., Milgram W. N., Cotman C. W., BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiology of Aging 2012 33 3 546 554 10.1016/j. neurobiolaging.2010.03.019
10. Rantamäki T., Hendolin P., Kankaanpää A., Mijatovic J., Piepponen P., Domenici E., Chao M. V., Männistö P. T., Castrén E., Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-C γ signaling pathways in mouse brain. Neuropsychopharmacology 2007 32 10 2152 2162 2-s2.0-34447121927 10.1038/sj.npp.1301345 (Pubitemid 47417694)
11. Zhang Y., Gu F., Chen J., Dong W., Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Research 2010 1366 141 148 2-s2.0-79251613635 10.1016/j.brainres.2010.09.095
12. O'Leary O. F., Wu X., Castren E., Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling. Psychoneuroendocrinology 2009 34 3 367 381 2-s2.0-59249099507 10.1016/j.psyneuen.2008.09.015
13. Taliaz D., Stall N., Dar D. E., Zangen A., Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Molecular Psychiatry 2010 15 1 80 92 2-s2.0-72949096531 10.1038/mp.2009.67
14. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., Castrén E., Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience 2003 23 1 349 357 2-s2.0-0037218768 (Pubitemid 36050437)
15. Monteggia L. M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., Parada L. F., Nestler E. J., Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biological Psychiatry 2007 61 2 187 197 2-s2.0-33846105118 10.1016/j.biopsych.2006.03.021 (Pubitemid 46072778)
16. Leonard B. E., Stress, norepinephrine and depression. Journal of Psychiatry and Neuroscience 2001 26 S11 S16 2-s2.0-0035571938 (Pubitemid 34218789)
17. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R., Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987 93 3 358 364 2-s2.0-0023636527 (Pubitemid 17160661)
18. Willner P., Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997 134 4 319 329 2-s2.0-0031440325 10.1007/s002130050456 (Pubitemid 28023396)
19. Onozuka H., Nakajima A., Matsuzaki K., Shin R. W., Ogino K., Saigusa D., Tetsu N., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 2008 326 3 739 744 2-s2.0-53849087537 10.1124/jpet.108.140293
20. Yamamoto Y., Shioda N., Han F., Moriguchi S., Nakajima A., Yokosuka A., Mimaki Y., Sashida Y., Yamakuni T., Ohizumi Y., Fukunaga K., Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Research 2009 1295 218 229 2-s2.0-70349260102 10.1016/j.brainres.2009.07.081
21. Yi L. T., Xu H. L., Feng J., Zhan X., Zhou L. P., Cui C. C., Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiology and Behavior 2011 102 1 1 6 2-s2.0-78049500586 10.1016/j.physbeh. 2010.10.008
22. Campbell S., Macqueen G., The role of the hippocampus in the pathophysiology of major depression. Journal of Psychiatry and Neuroscience 2004 29 6 417 426 2-s2.0-11344249233 (Pubitemid 40075713)
23. Berton O., Nestler E. J., New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews Neuroscience 2006 7 2 137 151 2-s2.0-31444441701 10.1038/nrn1846 (Pubitemid 43151600)
24. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A., The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. Journal of Molecular Neuroscience 2011 45 2 246 255 10.1007/s12031-011-9515-5
25. Yi L. T., Li J. M., Li Y. C., Pan Y., Xu Q., Kong L. D., Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Sciences 2008 82 13-14 741 751 2-s2.0-40649126076 10.1016/j.lfs.2008.01.007
26. Singh S. P., Wahajuddin, Tewari D., Patel K., Jain G. K., Permeability determination and pharmacokinetic study of nobiletin in rat plasma and brain by validated high-performance liquid chromatography method. Fitoterapia 2011 82 8 1206 1214 10.1016/j.fitote.2011.08.010
27. Saigusa D., Shibuya M., Jinno D., Yamakoshi H., Iwabuchi Y., Yokosuka A., Mimaki Y., Naganuma A., Ohizumi Y., Tomioka Y., Yamakuni T., High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound. Analytical and Bioanalytical Chemistry 2011 400 10 3635 3641 2-s2.0-79960651673 10.1007/s00216-011-5031-2
28. Willner P., Moreau J. L., Nielsen C. K., Papp M., Sluzewska A., Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiology and Behavior 1996 60 1 129 134 2-s2.0-0030183494 10.1016/0031-9384(95)02256-2 (Pubitemid 126335862)
29. Edgar V. A., Cremaschi G. A., Sterin-Borda L., Genaro A. M., Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine. Brain, Behavior, and Immunity 2002 16 4 333 350 2-s2.0-0036430128 10.1006/brbi.2001.0632 (Pubitemid 35346199)
30. Liu W., Zhou C., Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning. Psychoneuroendocrinology 2012 37 7 1057 1070 10.1016/j.psyneuen.2011.12.003
31. Gamaro G. D., Prediger M. E., Lopes J., Bassani M. G., Dalmaz C., Fluoxetine alters feeding behavior and leptin levels in chronically-stressed rats. Pharmacology Biochemistry and Behavior 2008 90 3 312 317 2-s2.0-44649118751 10.1016/j.pbb.2008.03.005
32. Casarotto P. C., Andreatini R., Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. European Neuropsychopharmacology 2007 17 11 735 742 2-s2.0-34548784929 10.1016/j.euroneuro.2007.03.001 (Pubitemid 47432838)
33. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders 2000 4th Washington, DC, USA APA Press
34. Pothion S., Bizot J. C., Trovero F., Belzung C., Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behavioural Brain Research 2004 155 1 135 146 2-s2.0-4344700859 10.1016/j.bbr.2004.04.008 (Pubitemid 39119974)
35. Kunimasa K., Kuranuki S., Matsuura N., Iwasaki N., Ikeda M., Ito A., Sashida Y., Mimaki Y., Yano M., Sato M., Igarashi Y., Oikawa T., Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion. Bioorganic and Medicinal Chemistry Letters 2009 19 7 2062 2064 2-s2.0-61849093805 10.1016/j.bmcl.2009.02.002
36. Kanda K., Nishi K., Kadota A., Nishimoto S., Liu M. C., Sugahara T., Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction. Biochimica et Biophysica Acta 2012 1820 4 461 468 10.1016/j.bbagen.2011.11.015
37. Lee Y. S., Cha B. Y., Choi S. S., Choi B. K., Yonezawa T., Teruya T., Nagai K., Woo J. T., Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice. The Journal of Nutritional Biochemistry 2013 24 1 156 162 10.1016/j.jnutbio.2012.03.014
38. Aihara M., Ida I., Yuuki N., Oshima A., Kumano H., Takahashi K., Fukuda M., Oriuchi N., Endo K., Matsuda H., Mikuni M., HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Research 2007 155 3 245 256 2-s2.0-34447272932 10.1016/j.pscychresns.2006.11.002 (Pubitemid 47042359)
39. Manthey L., Leeds C., Giltay E. J., van Veen T., Vreeburg S. A., Penninx B. W., Zitman F. G., Antidepressant use and salivary cortisol in depressive and anxiety disorders. European Neuropsychopharmacology 2011 21 9 691 699 10.1016/j.euroneuro.2011.03.002
40. Rohleder N., Wolf J. M., Wolf O. T., Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neuroscience and Biobehavioral Reviews 2010 35 1 104 114 2-s2.0-77955920927 10.1016/j.neubiorev.2009.12.003
41. Thakker-Varia S., Alder J., Neuropeptides in depression: role of VGF. Behavioural Brain Research 2009 197 2 262 278 2-s2.0-58149512288 10.1016/j.bbr.2008.10.006
42. Doczy E. J., Seroogy K., Harrison C. R., Herman J. P., Hypothalamo-pituitary-adrenocortical axis, glucocorticoids, and neurologic disease. Immunology and Allergy Clinics of North America 2009 29 2 265 284 2-s2.0-64849098693 10.1016/j.iac.2009.02.003
43. Li Y. C., Shen J. D., Li J., Wang R., Jiao S., Yi L. T., Chronic treatment with baicalin prevents the chronic mild stress-induced depressive-like behavior: involving the inhibition of cyclooxygenase-2 in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013 40 138 143 10.1016/j.pnpbp.2012.09.007
44. Nikisch G., Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuroendocrinology Letters 2009 30 1 11 16 2-s2.0-65349129516
45. Kitayama I., Janson A. M., Cintra A., Fuxe K., Agnati L. F., Ogren S. O., Harfstrand A., Eneroth P., Gustafsson J. A., Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla. Journal of Neural Transmission 1988 73 3 191 203 2-s2.0-0023713503
46. Barden N., Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry 1996 29 1 12 22 2-s2.0-0030029963 (Pubitemid 26071333)
47. Brady L. S., Whitfield H. J. Jr., Fox R. J., Gold P. W., Herkenham M., Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. The Journal of Clinical Investigation 1991 87 3 831 837 2-s2.0-0025729909
48. Lanfumey L., Mongeau R., Cohen-Salmon C., Hamon M., Corticosteroid- serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neuroscience and Biobehavioral Reviews 2008 32 6 1174 1184 2-s2.0-45849150032 10.1016/j.neubiorev.2008.04.006
49. Zunszain P. A., Anacker C., Cattaneo A., Carvalho L. A., Pariante C. M., Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 3 722 729 10.1016/j.pnpbp.2010.04.011
50. Barden N., Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. Journal of Psychiatry and Neuroscience 2004 29 3 185 193 2-s2.0-3042662118 (Pubitemid 38829855)
51. Sommerfeld M. T., Schweigreiter R., Barde Y. A., Hoppe E., Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. The Journal of Biological Chemistry 2000 275 12 8982 8990 2-s2.0-0034708738 10.1074/jbc.275.12.8982 (Pubitemid 30180257)
52. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R., Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Molecular Brain Research 2005 136 1-2 29 37 2-s2.0-18944406852 10.1016/j.molbrainres.2004.12.020 (Pubitemid 40704606)
53. Haenisch B., Bilkei-Gorzo A., Caron M. G., Bönisch H., Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. Journal of Neurochemistry 2009 111 2 403 416 2-s2.0-70349327748 10.1111/j.1471-4159.2009.06345.x
54. Lai H. C., Wu M. J., Chen P. Y., Sheu T. T., Chiu S. P., Lin M. H., Ho C. T., Yen J. H., Neurotrophic effect of citrus 5-hydroxy-3, 6, 7, 8, 3 ′ 4 ′ -hexamethoxyflavone: promotion of neurite outgrowth via cAMP/PKA/CREB pathway in PC12 cells. PLoS ONE 2011 6 11 e28280
55. Nibuya M., Morinobu S., Duman R. S., Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 1995 15 11 7539 7547 2-s2.0-0028815653
56. Dwivedi Y., Rizavi H. S., Conley R. R., Roberts R. C., Tamminga C. A., Pandey G. N., Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 2003 60 8 804 815 2-s2.0-0042154427 10.1001/archpsyc.60.8.804 (Pubitemid 36960912)
57. Balu D. T., Lucki I., Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neuroscience and Biobehavioral Reviews 2009 33 3 232 252 2-s2.0-59249098539 10.1016/j.neubiorev. 2008.08.007
58. Numakawa T., Suzuki S., Kumamaru E., Adachi N., Richards M., Kunugi H., BDNF function and intracellular signaling in neurons. Histology and Histopathology 2010 25 2 237 258 2-s2.0-74449091832
59. Shirayama Y., Chen A. C. H., Nakagawa S., Russell D. S., Duman R. S., Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 2002 22 8 3251 3261 2-s2.0-0037092425 (Pubitemid 35379212)
60. Kutiyanawalla A., Terry A. V. Jr., Pillai A., Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS ONE 2011 6 10 e26153
61. Gratacòs M., González J. R., Mercader J. M., de Cid R., Urretavizcaya M., Estivill X., Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 2007 61 7 911 922 2-s2.0-33947235663 10.1016/j.biopsych.2006.08.025 (Pubitemid 46420580)
62. Ibarguen-Vargas Y., Surget A., Vourc'h P., Leman S., Andres C. R., Gardier A. M., Belzung C., Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behavioural Brain Research 2009 202 2 245 251 2-s2.0-67349123686 10.1016/j.bbr.2009.03.040
63. Schmidt H. D., Duman R. S., The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 2007 18 5-6 391 418 2-s2.0-34548395111 10.1097/FBP.0b013e3282ee2aa8 (Pubitemid 47356367)
64. Alfonso J., Frick L. R., Silberman D. M., Palumbo M. L., Genaro A. M., Frasch A. C., Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biological Psychiatry 2006 59 3 244 251 2-s2.0-32144437619 10.1016/j.biopsych. 2005.06.036 (Pubitemid 43208971)
65. Barbiero V. S., Giambelli R., Musazzi L., Tiraboschi E., Tardito D., Perez J., Drago F., Racagni G., Popoli M., Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology 2007 32 12 2511 2519 2-s2.0-36249024272 10.1038/sj.npp.1301378 (Pubitemid 350126831)
66. Cesca F., Baldelli P., Valtorta F., Benfenati F., The synapsins: key actors of synapse function and plasticity. Progress in Neurobiology 2010 91 4 313 348 2-s2.0-77954202334 10.1016/j.pneurobio.2010.04.006
67. Vawter M. P., Thatcher L., Usen N., Hyde T. M., Kleinman J. E., Freed W. J., Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Molecular Psychiatry 2002 7 6 571 578 2-s2.0-0036024259 10.1038/sj.mp.4001158
68. Joëls M., Karst H., Alfarez D., Heine V. M., Qin Y., Van Riel E., Verkuyl M., Lucassen P. J., Krugers H. J., Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004 7 4 221 231 2-s2.0-17844386097 10.1080/10253890500070005 (Pubitemid 40591422)
69. Silva R., Mesquita A. R., Bessa J., Sousa J. C., Sotiropoulos I., Leão P., Almeida O. F. X., Sousa N., Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3 β Neuroscience 2008 152 3 656 669 2-s2.0-40949125640 10.1016/j.neuroscience.2007.12.026
70. Li N., Liu R. J., Dwyer J. M., Banasr M., Lee B., Son H., Li X. Y., Aghajanian G., Duman R. S., Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry 2011 69 8 754 761 2-s2.0-79953166373 10.1016/j.biopsych.2010.12.015
71. Schaaf M. J. M., de Jong J., de Kloet E. R., Vreugdenhil E., Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Research 1998 813 1 112 120 2-s2.0-0032583213 10.1016/S0006-8993(98)01010-5 (Pubitemid 29012524)
72. Mao Q. Q., Huang Z., Ip S. P., Xian Y. F., Che C. T., Peony glycosides reverse the effects of corticosterone on behavior and brain BDNF expression in rats. Behavioural Brain Research 2012 227 1 305 309 10.1016/j.bbr.2011.11.016
73. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hörtnagl H., Flor H., Kenn F. A., Schütz G., Gass P., Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. Journal of Neuroscience 2005 25 26 6243 6250 2-s2.0-21544434047 10.1523/JNEUROSCI.0736-05.2005 (Pubitemid 40923491)
74. Chao H. M., Sakai R. R., Ma L. Y., McEwen B. S., Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 1998 139 7 3112 3118 2-s2.0-0031789826 10.1210/en.139.7.3112 (Pubitemid 28512338)